| Moebius, Ulrich (MorphoSys 200902– Head Pre-clinical develop before Medigene) |
Research & Development Manager |
MorphoSys (Group) |
Germany |
| Moedas, Carlos (EU (govt) 201710 Commissioner for Research, Science + Innovation) |
Minister |
EU (govt) |
Luxembourg |
| Moelker, Adriaan (BRAIN 202002– CEO before Flint Group + AB Enzymes + Genencor + DSM) |
Chief Executive Officer (CEO) |
BRAIN Biotech (Group) |
Germany |
| Moellgaard, Henrik (Direvo Industrial Biotech 200807– before Christian Hansen) |
n. a. |
Direvo Industrial Biotechnology (Group) |
Germany |
| Moesslang, Angelo (InGeneron 201710– CEO before CFO at Fresenius Medial Care North America) |
Chief Executive Officer (CEO) |
InGeneron (Group) |
Germany |
| Mohadjer, Aydin (CAMAG 201302 Corporate Marketing Manager) |
Sales Manager / Marketing Manager |
CAMAG (Group) |
Switzerland |
| Mohan, Vikalp (Celonic 2021102 CBO 201609 VP Global Commercial Operations) |
Sales Manager / Marketing Manager |
Celonic (Group) |
Switzerland |
| Mohr, Bernhard (Evonik 201201– Head of Corporate Venturing) |
President/Director/Head Business Group/Unit/Division |
Evonik (Group) |
Germany |
| Mohr, Deana (Muvon Therapeutics 202104 CEO + Co-Founder) |
Chief Medical Officer (CMO) |
Muvon Therapeutics AG |
Switzerland |
| Mohr, Fabian (High-Tech Gründerfonds 201811) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Mohr, Heribert (Thermo Fisher 201304– Global Strategic BusDev Manager Chromatography + MS division) |
Business Development Manager / Strategy Manager |
Thermo Fisher (Group) |
Germany |
| Mohr, Lars (berlinbiotechpark 201104 Managing Director) |
Managing Director |
berlinbiotechpark GmbH & Co. KG |
Germany |
| Mohr, Mareike (MC Services 201207 Public Relations) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
| Mohr, Ulrich (Cultex Laboratories GmbH 201105 Managing Director + co-founder) |
Managing Director |
Cultex Laboratories GmbH |
Germany |
| Moingeon, Benjamin (GATC Biotech 201503 Sales Director) |
Sales Manager / Marketing Manager |
Eurofins (Group) |
Germany |
| Mol, Jan Willem (ModuVision Technologies 202206 CEO) |
Chief Executive Officer (CEO) |
Knauer (Group) |
Netherlands |
| Moldenbauer, Gerhard |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Moll, Fred (Ciruit Therapeutics 201312 Chairman) |
Board member |
Circuit Therapeutics Inc. |
United States (USA) |
| Moll, Gert (Lanthio Pharma 201410 CEO) |
Chief Executive Officer (CEO) |
MorphoSys (Group) |
Netherlands |
| Moll, Nathalie (EFPIA 201704– Director General before Secretary General at EuropaBio) |
President/Director/Head Business Group/Unit/Division |
EuropaBio aisbl – the European Association of Bioindustries |
Belgium |
| Moll, Peter (Otsuka 201103 Managing Director of ABX GmbH) |
Managing Director |
Otsuka (Group) |
Germany |
| Momsen, Björn (High-Tech Gründerfonds 201010 Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Monaghan, Paul (Psyros Diagnostics 202201 Head of Engineering + Co-Founder before Novartis NPTU/Vivacta) |
Chief Technology/Technical Officer (CTO) |
Prolight Diagnostics (Group) |
United Kingdom (GB) |
| Monin, Jean-Fabien (AC Immune 200901– CFO before 14y at bioMérieux CFO Central Europe) |
Chief Financial Officer (CFO) |
AC Immune S.A. (Nasdaq: ACIU) |
Switzerland |
| Monko, Michael (Sequenom 200608– Senior VP Sales + Marketing before UpState Chemicon before Invitrogen Corp) |
n. a. |
LabCorp (Group) |
United States (USA) |
| Monroe, Thomas Lawrence (Tom) (Actelion 201604 CEO of Vaxxilon AG) |
Chief Executive Officer (CEO) |
Idorsia (Group) |
Switzerland |
| Montag, Bernd (Siemens 201802 CEO of Siemens Healthineers) |
Chief Executive Officer (CEO) |
Siemens (Group) |
Germany |
| Montagner, Carlo (200801– CEO + Founder of STA before Alchemia + Abraxas Bioscience et al + Schering 200510) |
Chief Executive Officer (CEO) |
Specialised Therapeutics Australia Pty Ltd. (STA) |
Australia |
| Montana, John (Oxitope Pharma 202109– CEO joined as COO 4/20 also Operating Partner at Forbion before Charles River) |
Chief Executive Officer (CEO) |
Oxitope Pharma B.V. |
Netherlands |
| Montanari, Bruno (Seroba Life Sciences 201905 before Omnes Capital 201607 Partner) |
Partner (venture partner) |
Seroba (Group) |
Ireland, Republic of |
| Montenbruck, Ingo (Ingenium 200606 Senior Director BusDev) |
Business Development Manager / Strategy Manager |
Vivoryon (Group) |
Germany |
| Montero-MacColl, James (EasyFairs 202302 Senior Marketing Manager at EasyFairs UK) |
Sales Manager / Marketing Manager |
Artexis (Group) |
United Kingdom (GB) |
| Monz, Ludwin (Carl Zeiss 201401 CEO of Carl Zeiss Medictec AG) |
Chief Executive Officer (CEO) |
Carl Zeiss (Group) |
Germany |
| Moonen, Kees (Kreatech 200909– CEO before Green Cross Vaccine CEO) |
Chief Executive Officer (CEO) |
Danaher (Group) |
Netherlands |
| Moore, Jeffrey R. (Helicos 201208 SVP + CFO) |
Chief Financial Officer (CFO) |
Helicos BioSciences Corporation (Nasdaq: HLCS) |
United States (USA) |
| Moore, John (Scientific Industries 202104 Chairman + President of SBI) |
President/Director/Head Business Group/Unit/Division |
Scientific Industries (Group) |
United States (USA) |
| Moore, Judith (AC Immune 202003 Global Head of Communications) |
Public Relations Manager / Investor Relations Manager |
AC Immune S.A. (Nasdaq: ACIU) |
Switzerland |
| Moore, Kevin (Tecan 201011 Director Market and Application Management for BioPharma) |
Product Manager (personnel) |
Tecan (Group) |
Switzerland |
| Moosbauer, Julia (Deepc 202303 COO + Co-Founder) |
Chief Operating Officer (COO) |
Deepc GmbH |
Germany |
| Mora, Luis (Zeltia 201208– Managing Director of newly founded Pharma Mar GmbH) |
Managing Director |
PharmaMar (Group) |
Germany |
| Moradian, Eddie (MD Biosiences 202010 CEO) |
Chief Executive Officer (CEO) |
MLM Medical Labs (Group) |
United States (USA) |
| Morand, Olivier (Azafaros 201807– CEO before Idorsia + Actelion + Roche) |
Chief Executive Officer (CEO) |
Azafaros B.V. |
Netherlands |
| Moreno, Gerardo Cabanas (IPN 201203 Director of CMMN) |
Researcher (university / research institute) |
Instituto Politécnico Nacional (IPN) (National Polytechnic Institute, MX) |
Mexico |
| Morgan, Jeremy (Eli Lilly 201204 Managing Director of Lilly Deutschland GmbH) |
Managing Director |
Eli Lilly (Group) |
Germany |
| Morgan, Victoria (Lonza 202105 Head of External Communications) |
Public Relations Manager / Investor Relations Manager |
Lonza (Group) |
Switzerland |
| Morgenthaler, Nils G. (Bruker 201504 VP Medical Affairs at Bruker Daltonics division) |
n. a. |
Bruker (Group) |
United States (USA) |
| Morich, Frank (Takeda 201008– EVP International Operations before Noxxon CEO before Innogenetics + AM-Pharma + Bayer) |
President/Director/Head Business Group/Unit/Division |
Takeda (Group) |
Japan |
| Morie, Brad (Biocrates 200805 VP Business Development LEFT before 10/11) |
Business Development Manager / Strategy Manager |
Biocrates (Group) |
Austria |
| Morisawa, Atsushi (Koki Holdings 202003 CEO) |
Chief Executive Officer (CEO) |
Koki Holdings (Group) |
Japan |
| Morlock, Gerda (Univ Giessen 201302 Professor) |
Professor |
University of Gießen (Justus Liebig University) |
Germany |
| Moro, Luigi (Cassiopea 201509 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Cassiopea S.p.A. (SIX: SKIN) |
Italy |
| Moroney, Simon E. (MorphoSys 1992–201908 CEO + Founder STEPPED DOWN 9/19) |
Chief Executive Officer (CEO) |
MorphoSys (Group) |
Germany |
| Morrell, Graham (Paddock Circle Advisors 201808) |
Public Relations Manager / Investor Relations Manager |
Paddock Circle Advisors (US) |
United States (USA) |
| Morrill, Paul (Bit Bio 201912 CBO before Horizon Discovery 201109 Commercial Director of reagents division) |
Chief Business Officer (CBO) |
Bit Bio Ltd. (bit.bio) |
United Kingdom (GB) |
| Morris, Andrew (SQI Diagnostics 201107 CFO) |
Chief Financial Officer (CFO) |
SQI Diagnostics Inc. |
Canada |
| Morris, David (Novartis 201804 Venture Partner at NVF) |
Partner (venture partner) |
Novartis (Group) |
Switzerland |
| Morris, Howard R. (M-Scan 1997– founder + Imperial College London Prof) |
Company Founder |
SGS (Group) |
United Kingdom (GB) |
| Morrison, Andrea (Merck (DE) 201204 Merck Serono International SA Antibodies Technologies) |
n. a. |
Merck (DE) (Group) |
Switzerland |
| Morrison, David (Murdoch Univ 201909 Professor + Deputy Vice Chancellor for Research + Innovation) |
Professor |
Murdoch University |
Australia |
| Morrison, Jodie (Cadent Therapeutics 202012 CEO formerly Tokai Pharmaceuticals 201503 CEO) |
Chief Executive Officer (CEO) |
Novartis (Group) |
United States (USA) |
| Morscher, Elmar (Integra Biosciences 200808 CEO) |
Chief Executive Officer (CEO) |
Integra Holding (Group) |
Switzerland |
| Moser, Christian (Pevion Biotech 201201 Head of Research) |
Research & Development Manager |
Pevion Biotech AG |
Switzerland |
| Moser, Markus (Prionics AG 201403 CEO) |
Chief Executive Officer (CEO) |
Thermo Fisher (Group) |
Switzerland |
| Moser, Thomas (Haplogen 201410 CEO) |
Chief Executive Officer (CEO) |
Haplogen Bioscience GmbH |
Austria |
| Moses, Edwin (Ablynx 200603– CEO before non-exec Board Member 200411– before Oxford Asymmetry) |
Chief Executive Officer (CEO) |
Sanofi (Group) [since May 2011] |
Belgium |
| Moss, Dean (Univ Queensland 201909 CEO of UniQuest) |
Chief Executive Officer (CEO) |
University of Queensland (UQ) |
Australia |
| Moss, Jeremy (Roche 201207 Global Head of Point of Care at Roche Professional Diagnostics in Rotkreuz) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
Switzerland |
| Most, Patrick (Aavigen 201905– Managing Director + Inocard 201401– Managing Director + Co-founder) |
Managing Director |
Uniqure (Group) |
Germany |
| Mothes, Harald (Solvay 201108 Executive Board Director) |
Board member, executive |
Solvay (Group) |
Germany |
| Mothes, Helmut (Bayer Technology Services 200409) |
n. a. |
Bayer (Group) |
Germany |
| Motschmann, Michael (MIG Funds 200604) |
Investment Manager |
MIG Fonds (Group) |
Germany |
| Motz, Manfred (Mikrogen 2003) |
n. a. |
Mikrogen GmbH |
Germany |
| Mouney, Jean-François (Genfit 201909– Board Chairman before 1999–201909 CEO + Co-Founder) |
Board member, non-executive |
Genfit (Group) |
France |
| Mounier, Théophile (Lunaphore 202105 Corporate Finance) |
Financial Manager (CFO, Financial Director, etc.) |
Bio-Techne (Group) |
Switzerland |
| Mouritsen, Søren (Engimmune Therapeutics 202205 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Engimmune Therapeutics AG |
Switzerland |
| Mous, Jan (Midatech 2010– CEO of PharMida AG before IntegraGen + Lion Bioscience + Roche) |
Chief Executive Officer (CEO) |
Midatech (Group) |
Switzerland |
| Mousa, Ahmed (Pieris 202110– promoted to CBO joined 2016 as SVP CorpOp + General Counsel before Covington & Burlington) |
Chief Business Officer (CBO) |
Pieris (Group) |
United States (USA) |
| Moussa, Roland (ProtaGene 202201 Managing Director of PortaGene GmbH) |
Managing Director |
ProtaGene (Group) |
Germany |
| Mouz, Nicolas (PX'Therapeutics 201008– CEO of Promise Advanced Proteomics) |
Chief Executive Officer (CEO) |
Aguettant (Group) |
France |
| Mu, Hu (Grande Bio-tech Co Ltd 202309 Managing Director) |
Managing Director |
Grande Bio-tech Co. Ltd. |
China |
| Mucke, Hermann (H.M. Pharma Consultancy) |
Consultant (economic/technology) |
H.M. Pharma Consultancy [Hermann Mucke Pharma Consultancy e.U.] |
Austria |
| Mucke, Lennart (Gladstone Institute 201006 Director) |
Professor |
Gladstone Institutes (Group) |
United States (USA) |
| Mudde, Geert C. (S-Target Therapeutics 201310 Managing Director + Co-founder) |
Managing Director |
S-Target Therapeutics GmbH |
Austria |
| Mueller, André J. (Addex 201106 Chairman of the Board before Actelion CFO before Biogen before Sandoz) |
Board member, non-executive |
Addex (Group) |
Switzerland |
| Mueller, Stefan (CureVac 201902– VP Preclinical before Sandoz Biopharmaceuticals + Merck Serono + Merck + Knoll GmbH) |
Research & Development Manager |
CureVac (Group) |
Germany |
| Muellershausen, Florian (Novartis 201902 Novartis Venture Fund) |
Investment Manager |
Novartis (Group) |
Switzerland |
| Muirhead, Gary (Ixchelsis Ltd 201308 CEO) |
Chief Executive Officer (CEO) |
Ixchelsis Ltd. |
United Kingdom (GB) |
| Muken, Ross (Sophia Genetics 202102– CFO before Click Therapeutics 201907– CFO before ISI Group + Deutsche Bank) |
Chief Financial Officer (CFO) |
Sophia Genetics (Group) |
Switzerland |
| Mukhanov, Alexey (Nanohale 201110– Managing Director of RusNanohale) |
Managing Director |
Formycon (Group) |
Russian Federation |
| Mukherjee, Anindya (Direvo Industrial Biotech 200807– before DSM) |
n. a. |
Direvo Industrial Biotechnology (Group) |
Germany |
| Mukhopadhyay, Amal K. (ELGA Biotech 200905) |
Company Founder |
ELGA Biotech (Hamburg) |
Germany |
| Mulder, Eva (Trophic Commincations 202005– Account Director before Uniqure) |
Public Relations Manager / Investor Relations Manager |
Trophic Communications GmbH |
Germany |
| Mulet, Miguel (Genetrix 201207 Business Development Director before Janssen Pharmaceutica + co-founder of Mirada) |
Business Development Manager / Strategy Manager |
2invest (Group) |
Spain (España) |
| Muller, André C. (Idorsia 201706– CFO before Actelion 201309– CFO before Pierre Fabre CFO) |
Chief Financial Officer (CFO) |
Idorsia (Group) |
Switzerland |
| Muller, Arnaud (Nemis Technologies 202202 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Nemis Technologies AG |
Switzerland |
| Mummenbrauer, Torsten (ExeVir Bio 202006– CEO before Velvio Gmbh + Hookipa + MorphoSys + GSK Vaccines) |
Business Development Manager / Strategy Manager |
ExeVir Bio B.V. |
Belgium |
| Munch, Mark R. (Bruker Corp 201407 President Bruker MAT Group before President Bruker Nano Surfaces Business) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
United States (USA) |
| Mund, Matthias (Dako Deutschland GmbH 200706 Managing Director) |
Managing Director |
Agilent (Group) |
Germany |
| Mundel, Trevor (Novartis 200805 Head Global Development Functions Novartis Pharma AG) |
Research & Development Manager |
Novartis (Group) |
Switzerland |
| Mundus, Jana (PharmAI 202204 Public Relations) |
Public Relations Manager / Investor Relations Manager |
PharmAI GmbH |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 51 52 53 ... 86 87 88 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
